Chair(s): Anita Simonds, Sebastien Baillieul
Session type: Symposium
Session content
Winfried J. Randerath
Replay
Renaud Tamisier
Replay
Michael Arzt
Replay
Discussion and Q&A
Replay
Session aims
1.Examine the clinical features, outcome and rationale for treating CSA with ASV 2.Understand underlying phenotypes of CSA 3.Review the results of the Face, Advent and Serve-HF trials and how these impact on treatment of CSA